Multiple ways to switch platelet integrins on and off
Current perspective of venous thrombosis in the upper extremity
Upper extremity deep vein thrombosis – not the same disease at a different site
Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence
Pulmonary capillary endothelial metabolic function in chronic thromboembolic pulmonary hypertension
Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy
Delayed adverse vascular events after splenectomy in hereditary spherocytosis
Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study
Plasma and albumin-free recombinant factor VIII
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
Fibrophilia
Coagulation status modulates murine hepatic fibrogenesis
Tissue factor pathway inhibitor-γ is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A
The cut of the clot(h)
Bothrops protease A, a unique highly glycosylated serine proteinase, is a potent, specific fibrinogenolytic agent
eNOS, iNOS or no NOS, that is the question!
NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity
Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase-2
Rapid resensitization of purinergic receptor function in human platelets
Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2′
Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets
A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aα Arg439→Cys
Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase does not inhibit the platelet procoagulant response
Conformational (in)stability of rat vs. human activated thrombin activatable fibrinolysis inhibitor
Founder haplotype associated with the factor VIII Asp1241Glu polymorphism in a cohort of mild hemophilia A patients
Inherited protein S deficiency as a reszult of a large duplication mutation of the PROS1 gene detected by multiplex ligation-dependent probe amplification
Pursuing the debate on the serologic criteria that define the antiphospholipid syndrome
Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
More on
More on
Join ISTH